Ctxr analyst report
WebMar 31, 2024 · The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays ... WebIn this section, we analyze the profitability of every unplanned, open-market insider purchase made in CTXR / Citius Pharmaceuticals Inc. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical .
Ctxr analyst report
Did you know?
WebApr 10, 2024 · Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned CTXR a recommendation rating is 3. Web20 hours ago · Citius Pharmaceuticals (CTXR) Jumps: Stock Rises 5.1% 06/30/20-7:54AM EST Zacks. Other News for CTXR Maxim Group Reaffirms Their Buy Rating on Citius …
WebFeb 20, 2024 · An analysis of the Citius Pharmaceuticals Inc. (NASDAQ:CTXR) stock in terms of its daily trading volume indicates that the 3-month average is 826.91K. However, this figure increases on the past 10-day timeline to an average of 0.7 million. Current records show that the company has 146.15M in outstanding shares. WebApr 5, 2024 · According to the issued ratings of 1 analysts in the last year, the consensus rating for Citius Pharmaceuticals stock is Buy based on the current 1 buy rating for …
WebMar 30, 2024 · CTXR Analyst Estimates Stock Screener Earnings Calendar Sectors Nasdaq CTXR U.S.: Nasdaq Citius Pharmaceuticals Inc. Watch list Create CTXR Alert … Web1 day ago · Citius Pharmaceuticals (CTXR) Jumps: Stock Rises 5.1% 06/30/20-7:54AM EST Zacks. Other News for CTXR Maxim Group Reaffirms Their Buy Rating on Citius Pharmaceuticals (CTXR) 04/04/23-11:25AM EST ...
WebApr 3, 2024 · View CTXR revenue estimates and earnings estimates, as well as in-depth analyst breakdowns. ... CTXR will report FY 2024 earnings on 12/13/2024.
WebCitius Pharmaceuticals, Inc. (CTXR) Analyst Ratings, Estimates & Forecasts - Yahoo Finance U.S. markets closed S&P 500 4,105.02 +14.64(+0.36%) Dow 30 33,485.29 … cincinnati reds computer wallpaperWebFind the latest Citius Pharmaceuticals, Inc. (CTXR) stock quote, history, news and other vital information to help you with your stock trading and investing. dhss public healthWebApr 13, 2024 · CTXR Stock Price Performance Analysis. Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Until today this year the stock’s price performance recorded an increase of 98.73%. However, over the last six months, the performance has been … dhssps regional policy for day servicesWebApr 13, 2024 · The stock is rated as a Hold by 0 analyst(s), 3 recommend it as a Buy and 0 called the CTXR stock Overweight. In the meantime, 0 analyst(s) believe the stock as Underweight and 0 think it is a Sell. Thus, investors eager to increase their holdings of the company’s stock will have an opportunity to do so as the average rating for the stock is Buy. cincinnati reds dayton daily newsWeb2 days ago · Company Profile CTXR. Business Description. Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, unique … cincinnatireds.com official websiteWebCitius Pharma Stock (NASDAQ:CTXR), Analyst Ratings, Price Targets, Predictions. Analysts publish ratings and price targets on most stocks. cincinnati reds cooperstown hatWeb20 hours ago · Citius Pharmaceuticals (CTXR) Jumps: Stock Rises 5.1% 06/30/20-7:54AM EST Zacks. Other News for CTXR Maxim Group Reaffirms Their Buy Rating on Citius Pharmaceuticals (CTXR) 04/04/23-11:25AM EST ... dhss public health lab